Lucid Diagnostics and argenex SE are listed on the Nasdaq and are competing healthcare companies.
2 reports, 1 independent
Updated Sep 12
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Lucid Diagnostics and argenex SE are listed on the Nasdaq and are competing healthcare companies.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Nasdaq
American fully electronic stock exchange
Related events
- Argenex SE and Capricor Therapeutics were listed on the Nasdaq stock exchange and are competing in the biotech sector.
- Korro Bio, Inc. and Wellgistics Health were listed on the Nasdaq stock exchange on July 1, 2026.
- HCW Biologics announced it is listed on the Nasdaq stock exchange.
- Generate Biomedicines Inc listed its shares on the Nasdaq stock exchange on August 25, 2026.
- Cardiol Therapeutics Inc. is listed on Nasdaq and is developing therapy for an FDA-approved indication.